Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,655 across all filing types
Latest filing 2023-06-29 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
独立董事关于第三届董事会第十八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding matters discussed at the 18th meeting of the third board of directors of Shenzhen BGI Genomics Co., Ltd. It includes opinions on adjustments to related party transactions, the election of an independent director, and the appointment of a chief operating officer. The content focuses on governance and board-level decisions rather than financial results or regulatory filings. There is no indication of financial statements, audit reports, or earnings data. The document is not a report publication announcement or a certification. It fits best under Board/Management Information (MANG) as it announces changes and opinions related to board and senior management matters.
2023-06-29 Chinese
第三届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 18th meeting of the third board of directors of Shenzhen BGI Genomics Co., Ltd. It includes information about board meeting procedures, voting results, appointment of a COO, establishment of an ESG committee, and other board-related decisions. There is no financial data or financial statements presented. The document is not an annual or interim report, earnings release, or audit report. It is not a call transcript or investor presentation. The content focuses on board decisions and management changes, including appointments and committee formations. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 4051 characters, which is sufficient for a detailed board meeting resolution announcement. Confidence is high due to the clear focus on board resolutions and management appointments.
2023-06-29 Chinese
第三届监事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Shenzhen BGI Genomics Co., Ltd. regarding adjustments to the 2023 annual related party transactions and the increase of the estimated transaction amount. It details the meeting date, attendance, voting results, and compliance with relevant laws. There is no financial report or detailed financial data presented, nor is it an announcement of a report publication. The content focuses on board-level decisions and approvals related to company operations and governance. This fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies.
2023-06-29 Chinese
关于独立董事任期届满辞任的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of an independent director due to term expiration. It details the director's tenure, reasons for resignation, and the company's plan to elect a new director. There is no financial data, no report attached or referenced as being published, and no mention of financial results or regulatory certifications. The content clearly relates to changes in the company's board of directors. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming the classification.
2023-06-05 Chinese
2022年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2022 annual profit distribution (dividend) plan approved at the 2023 Annual General Meeting. It details the dividend amount, payment dates, shareholder eligibility, and related adjustments. It does not contain full financial statements or comprehensive financial performance data, but rather focuses on dividend distribution specifics. This matches the definition of a Notice of Dividend Amount (DIV). The document length is 2612 characters, which is relatively short and consistent with a dividend announcement rather than a full annual report or interim report.
2023-05-30 Chinese
关于回购控股子公司华大数极生物科技（深圳）有限公司少数股东股权暨关联交易的进展公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the progress of a share repurchase transaction involving a controlling subsidiary of the company. It details the completion of the repurchase of minority shareholders' equity, changes in the subsidiary's ownership structure, and updated business registration information. There are no financial statements or comprehensive financial data presented. The document is relatively short (1936 characters) and focuses on a specific capital transaction and related regulatory filings. This fits the category of a Transaction in Own Shares (POS) filing, which covers company buybacks or share repurchases.
2023-05-10 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.